Noven Announces 2008 Third Quarter Earnings Release Date

Noven Pharmaceuticals, Inc. announced its 2008 third quarter earnings release date.

On November 6, 2008, before the U.S. market opens, Noven is scheduled to issue a press release announcing its financial results for the three-month and nine-month periods ended September 30, 2008. At 11:00 a.m. ET the same day, a conference call with management is scheduled to be webcast live at www.noven.com, and thereafter a rebroadcast will be available at the same site for at least two weeks. A taped replay of the call will be available beginning November 6 through November 8 by calling 877-660-6853 (from within the U.S.) or 201-612-7415 (from outside the U.S.) and entering the access code 286 and conference ID number 299214.

About Noven

Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. Noven’s business and operations are focused in three principal areas – transdermal drug delivery, the Novogyne joint venture, and Noven Therapeutics, Noven’s specialty pharmaceutical unit. For more information about Noven Pharmaceuticals, visit www.noven.com.


Contact:

Noven Pharmaceuticals, Inc., Miami
Alina Bowman, Investor Relations Coordinator
305-253-1916

Source: Noven Pharmaceuticals, Inc.